Melatonin can reduce the levels of mitophagy proteins PINK1 and Parkin, decrease the colocalization of Tom20 and LC3, alleviate neuronal hypoxia after stroke, and improve post-stroke cognitive impairment (PSCI) (130). This evidence concerns the gene MAP1LC3A and stroke disorder.